March 26, 2020 / 7:11 AM / 4 days ago

BRIEF-UK's CMA Invites Comments On Dechra Pharmaceuticals, Elanco Animal Health

March 26 (Reuters) -

* UK’S CMA INVITES COMMENTS ON ANTICIPATED ACQUISITION BY DECHRA PHARMACEUTICALS PLC OF OSURNIA BUSINESS OF ELANCO ANIMAL HEALTH INCORPORATED

* THE COMPETITION AND MARKETS AUTHORITY (CMA) IS CONSIDERING WHETHER A DEAL WOULD CREATE A MERGER SITUATION, LEAD TO A SUBSTANTIAL LESSENING OF COMPETITION WITHIN ANY UK MARKET. Source text for Eikon: Further company coverage: [ ] (Reporting By Simon Jessop)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below